Loading
רקח is a listed company. Its directors and officers file their transactions with TASE (ISA). In the past year (18 October 2025 to 18 October 2026), 7 filings came from 7 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 530 companies) published 13 filings over the same period, against 7 filings here.
No insider has bought רקח shares on the open market in the past twelve months.
These figures are compiled from regulatory filings published by TASE (ISA). They describe what insiders did and are not a recommendation.
· cache
7 of 7 declarations
Rakeach is a publicly traded company on the Tel Aviv Stock Exchange, specializing in the pharmaceutical sector. It focuses on the research and development of innovative medical products.